RT info:eu-repo/semantics/article
T1 Agreement of tear break-up time and meniscus height between Medmont E300 and Visionix VX120+
A1 Martínez Plaza, Elena
A1 Molina Martín, Ainhoa
A1 Piñero, David P.
K1 Eye - Diseases - Treatment
K1 Ojo - Enfermedades y defectos - Tratamiento
K1 Dry eye syndromes
K1 Síndrome de ojo seco
K1 Ophthalmology
K1 Materials science
K1 Ciencia de los materiales
K1 Medical technology
K1 32 Ciencias Médicas
K1 3201.09 Oftalmología
K1 3314 Tecnología Médica
AB The goal of this study was to analyze the agreement between the Medmont E300 and the Visionix VX120+ systems in terms of non-invasive tear break-up time (NIBUT) and tear meniscus height (TMH) measurements. A total of 60 eyes (30 healthy subjects) were enrolled. NIBUT and TMH were evaluated with Medmont E300; first NIBUT, NIBUT50%, and TMH were evaluated with Visionix VX120+. Both evaluations were performed in a random order by the same clinician for right, left, and both eyes. The Medmont E300 provided significantly higher NIBUT than Visionix VX120+ for first NIBUT in right, left, and both eyes (p ≤ 0.003) and NIBUT50% in left and both eyes (p ≤ 0.042). The TMH measured with VX120+ was significantly higher than with Medmont E300 considering both eyes (p = 0.037). No significant correlations were found between both devices for either NIBUT (p ≥ 0.11) or TMH (p ≥ 0.09). Passing–Bablok regression analyses revealed poor agreement between devices for NIBUT and TMH outcomes. VX120+ is expected to provide substantial lower first NIBUT values than the NIBUT measured by Medmont E300. Clinicians should consider not using both instruments as interchangeable for dry eye diagnosis.
PB MDPI
SN 2076-3417
YR 2022
FD 2022
LK https://uvadoc.uva.es/handle/10324/63159
UL https://uvadoc.uva.es/handle/10324/63159
LA eng
NO Applied Sciences, 2022, Vol. 12, Nº. 9, 4589
NO Producción Científica
DS UVaDOC
RD 10-jun-2024